CDC approves Novavax; first protein-based COVID-19 vaccine – The Chronicle-News


Colorado Department of Public Health and Environment Centers for Disease Control and Prevention (CDC) gave final approval for use of the Novavax COVID-19 vaccine in adults aged 18 and older, as a two-dose primary COVID-19 vaccine series with the two doses separated by three weeks.

Subscribe Now to continue reading.
Log In
Join Now



Source link

Ozinize
Logo
Shopping cart